Description
Retatrutide is a synthetic peptide compound functioning as a triple agonist targeting the gastric inhibitory polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors. This multi-receptor agonist is structured for laboratory research evaluating metabolic signaling pathways, endocrine regulation, and receptor binding affinity in vitro and in vivo models.

Reviews
There are no reviews yet.